Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>CLSA Lifts WUXI APPTEC (02359.HK) TP to $149.3, Keeps Outperform Rating
Recommend 3 Positive 1 Negative 0 |
||||
|
||||
|
WUXI APPTEC (02359.HK)(603259.SH) will announce its 1Q26 results next Monday (27th), CLSA issued a research report saying. The broker expected earnings momentum to continue accelerating, with an improved business mix and room for valuation re-rating. CLSA forecasted its 1Q26 revenue to grow 20% YoY, including a 25% YoY increase in revenue from continuing operations. High-margin TIDES business and the divestment of low-growth clinical CRO operations are expected to drive adjusted non-IFRS net profit growth of over 35% YoY. Therefore, the broker kept ratings at Outperform for both the H-/ A-shares of WUXI APPTEC, and lifted its target prices from $144.4/ RMB126.7 to $149.3/ RMB130.9, based on an unchanged 20x PE ratio prediction for 2027. Auto-translated by AI AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
